MichaelCSoulenMD

Radiology • Philadelphia, PA

Interventional Neuroradiology, Vascular & Interventional Radiology

Professor of Radiology, University Pennsylvania

Join to view full profile

Dr. Soulen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Soulen's full profile

Already have an account?

Office
3400 Spruce St
# Ground
Philadelphia, PA 19104
Phone+1 215-662-3005

Fax+1 215-662-7011

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Vascular and Interventional Radiology, 1989 - 1991
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiology-Diagnostic, 1989 - 1991
Johns Hopkins UniversityResidency, Radiology-Diagnostic, 1985 - 1989
Johns Hopkins University/Bayview Medical CenterInternship, Internal Medicine, 1984 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1984

Certifications & Licensure

NJ State Medical License 2023 - 2025
PA State Medical License 1990 - 2024
NC State Medical License 2020 - 2022
MD State Medical License 1988 - 1989
American Board of Radiology Interventional Radiology and Diagnostic Radiology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Philadelphia Magazine Castle Connolly, 2004-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FSIR) Society of Interventional Radiology
Join now to see all

Clinical Trials

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) Start of enrollment: 2001 Nov 01
Terminated
Phase 3
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 1
HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer Start of enrollment: 2011 Jun 01
Terminated
Phase 3
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
Completed
Not Applicable
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver Start of enrollment: 2016 Mar 01
Active, not recruiting
Phase 2
CapTemY90 for Grade 2 NET Liver Metastases Start of enrollment: 2021 Oct 07
Recruiting
Phase 2
CapTem Plus Radioembolization for NET Liver Metastases Start of enrollment: 2021 Nov 01
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal Start of enrollment: 2022 Nov 28
Recruiting
Phase 3
Roles: Contact, Principal Investigator
TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) Start of enrollment: 2022 Jan 24
Terminated
Phase 1
Roles: Contact, Principal Investigator
Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary Start of enrollment: 2020 Aug 26
Terminated
Phase 1
Roles: Contact
QOL and Sarcopenia in Patients With Ascites Start of enrollment: 2023 May 23
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

76 citations
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.
Thorvardur R Halfdanarson, Jonathan R Strosberg, Laura Tang, Andrew M Bellizzi, Emily K Bergsland
Pancreas. 2020-08-01
269 citations
Neuroendocrine and adrenal tumors, version 2.2021
Manisha H. Shah, Whitney S. Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky
Journal of the National Comprehensive Cancer Network. 2021-07-28
618 citations
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen
Cancer Immunology Research. 2014-02-01

Lectures

24th Annual Fall Foliage Cancer Conference
Northwest AHEC, Asheville, North Carolina - 10/19/2012

Press Mentions

Roundtable Discussion: Has Interventional Oncology Established Itself as the Fourth Pillar of Oncology?October 24th, 2022
Neuroendocrine Cancer Program: Not a Rare Cancer at Penn MedicineOctober 4th, 2021
Minimally Invasive Cancer Treatments HighlightedNovember 28th, 2005
Join now to see all